Clinical trial

Comparison of Three Treatments for Pneumocystis Pneumonia in AIDS Patients

NCT00000730 · National Institute of Allergy and Infectious Diseases (NIAID), NIH · Terminated

Key facts

NCT number NCT00000730
Title Comparison of Three Treatments for Pneumocystis Pneumonia in AIDS Patients
Official title A Randomized, Comparative Trial of Trimetrexate With Leucovorin Rescue Versus Standard Anti-Pneumocystis Therapy Versus Standard Anti-Pneumocystis Therapy With High Dose Steroids for AIDS Patients With Pneumocystis Pneumonia Who Appear to Be Refractory to Conventional Drugs
Lead sponsor National Institute of Allergy and Infectious Diseases (NIAID), NIH
Status Terminated
Phase Phase 3
Study type Interventional
Conditions Pneumonia, Pneumocystis Carinii, HIV Infections
Intervention type Drug
Interventions Trimetrexate glucuronate, Methylprednisolone, Pentamidine isethionate, Sulfamethoxazole-Trimethoprim, Leucovorin calcium
Enrollment 240
Completion Mar 1, 1989
First posted Aug 31, 2001
Last update posted Nov 3, 2021
Countries United States

At a glance

  • 1–9 Study sites
  • No Results posted
  • None Linked FDA submissions

Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.

About ClinicalTrials.gov studies

ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.

Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date:

Browse all ClinicalTrials.gov studies